吸烟,慢性疼痛和处方阿片类药物使用之间的联系:2013-2021年
William Encinosa1, Didem Bernard2, R Burciaga Valdez3
1Division of Research and Modeling, Center for Financing, Access, and Cost Trends, Agency for Healthcare Research and Quality, Rockville, MD, United States; McCourt School of Public Policy, Georgetown University, Washington, DC, United States.
The journal of pain
|October 15, 2024
概括
吸烟与更多的慢性疼痛和更高的处方阿片类药物使用有关. 戒烟显著减少了疼痛和阿片类药物消费,强调了将戒烟纳入疼痛管理的好处.
科学领域:
- 公共卫生 公共卫生
- 疼痛管理 疼痛管理
- 成 药物 药物 药物 药物
背景情况:
- 众所周知,吸烟是导致慢性疼痛的一个因素.
- 吸烟,慢性疼痛和处方阿片类药物使用之间的关系需要进一步调查.
研究的目的:
- 检查吸烟状态与阿片类药物开始,停止和强度之间的关联.
- 评估戒烟对疼痛和阿片类药物使用结果的影响.
主要方法:
- 对全国代表性调查数据 (2013-2021) 的分析,将医疗支出小组调查和国家健康访谈调查联系起来.
- 用多项逻辑回归模型分析了大量成年人队列 (N=36,796) 的结果.
主要成果:
- 吸烟成年人占人口的16%,但占阿片类药物处方的30%和MMEs的40%.
- 患有严重疼痛和工作限制的吸烟者使用了20%的MME.
- 吸烟成年人患慢性疼痛的风险更高,开始/继续服用阿片类药物,MME剂量更高 (≥50).
- 戒烟导致阿片类药物使用减少了20%,并在一年后疼痛减少了23%.
结论:
- 戒烟与慢性疼痛和处方阿片类药物使用的显著减少有关.
- 将戒烟融入疼痛管理计划为患者提供了一个非常有益的策略.
- 解决吸烟问题对于有效的慢性疼痛和阿片类药物使用管理至关重要.
相关概念视频
Analgesia and Pain Management
540
Pain is critical to various clinical pathologies, provoking an urgent need for effective management. Pain, whether acute or chronic, is a complex neurochemical process. Its alleviation depends on the type, with nonopioid analgesics effective for mild to moderate pain, such as musculoskeletal or inflammatory pain, while neuropathic pain responds best to anticonvulsants, tricyclic antidepressants, or serotonin/norepinephrine reuptake inhibitors. For severe acute or chronic pain, opioids may be...
540
Opioid Analgesics: Synthetic and Semisynthetic Opioids
237
Synthetic and semisynthetic opioids are pivotal in pain management and tackling opioid addiction. Semisynthetic opioids, including morphinans (morphine derivatives), oxycodone, oxymorphone, hydrocodone, and hydromorphone, have improved pharmacokinetic profiles compared to morphine. Additionally, heroin and 6-MAM (6-Monoacetylmorphine) show better CNS penetration than morphine due to heightened lipid solubility. Hydromorphone, a potent opioid, undergoes hepatic metabolism to form the active...
237
Opioid Analgesics: Morphine and Other Natural Cogeners
188
Opioids are a class of drugs that mimic endogenous opioid peptides and act on opioid receptors, and help in pain relief. These compounds are classified as natural, synthetic, or semi-synthetic. Natural opioids, like morphine, codeine, and thebaine, are derived from the opium poppy plant (Papaver somniferum or Papaver album) and are termed opiates. Synthetic opioids are artificial, while semi-synthetic opioids combine natural and synthetic compounds. Morphine, a prototypical opioid, possesses a...
188
Stress Prevention and Stress Management Techniques IV
26
Stress often leads to unhealthy habits like smoking, excessive drinking, and overeating, which offer short-term relief but ultimately increase long-term health risks. These behaviors create a cycle that temporarily lowers stress levels but can result in severe long-term health consequences. Breaking these habits is essential to reduce the risk of chronic diseases and improve overall well-being. Three primary changes that support better health include quitting smoking, reducing alcohol intake,...
26
Nociception
27.7K
Nociception—the ability to feel pain—is essential for an organism’s survival and overall well-being. Noxious stimuli such as piercing pain from a sharp object, heat from an open flame, or contact with corrosive chemicals are first detected by sensory receptors, called nociceptors, located on nerve endings. Nociceptors express ion channels that convert noxious stimuli into electrical signals. When these signals reach the brain via sensory neurons, they are perceived as pain.
27.7K
Opioid Receptors: Overview
555
Opioid receptors, including the mu (μ, MOR), delta (δ, DOR), and kappa (κ, KOR) types, belong to the rhodopsin family of G protein-coupled receptors. These receptors are located throughout the central and peripheral nervous systems and in non-neuronal tissues such as macrophages and astrocytes. Opioid receptor ligands can be categorized into agonists or antagonists. Highly selective agonists include [d-Ala2, MePhe4, Gly(ol)5]-enkephalin or DAMGO for MOR, [D-Pen2,...
555


